About Careers Internship MedBlog Contact us

Adjuvant Chemotherapy After Bladder Cancer Surgery Improved Survival

by Dr. Trupti Shirole on March 1, 2015 at 5:42 AM
 Adjuvant Chemotherapy After Bladder Cancer Surgery Improved Survival

Patients who received chemotherapy after bladder cancer surgery demonstrated an approximately 30 percent lower risk of death than those patients who underwent surgery alone, revealed an analysis by researchers at the Icahn School of Medicine at Mount Sinai and the Lahey Clinic in Burlington, MA.

Researchers used a large database of patients diagnosed with cancer in the United States. They analyzed 5,653 patients, of which 1,293 patients received adjuvant chemotherapy versus 4,360 patients who received surgery alone. They found that patients receiving adjuvant chemotherapy after surgical treatment had improved overall survival when compared to patients who received surgical treatment alone with only post-surgical observation.


Lead researcher Dr. Galsky said, "Until now, data supporting adjuvant chemotherapy has been mixed. Our analysis of actual cases supports the use of chemotherapy after surgery for patients with locally advanced bladder cancer. Chemotherapy prior to surgery remains the optimal approach for patients with bladder cancer based on the available evidence. However, population-based observational studies may be used to help fill the knowledge void in situations where clinical trials have not yielded definitive evidence. This comparative effectiveness analysis may help inform the care of patients with bladder cancer who have not received chemotherapy prior to surgery."

The study will be presented at the 2015 Genitourinary Cancers Symposium.

Source: Medindia
Font : A-A+



Recommended Readings

Latest Cancer News

Breast Reconstruction and Shorter Radiation: The Winning Combo!
Shorter radiation course is just as good as the regular one for women choosing breast reconstruction after mastectomy, saving time and money.
Innovative Cancer Implant Technology Holds Promise to Cut Death Rates by Half
HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.
Personalized Vaccine and T Cell Therapy for Ovarian Cancer Patients
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Kinase-Targeted Therapy Revolutionizes Colorectal Cancer Care
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
Novel Photo-Oxidation Therapy Holds Promise for Anticancer Treatment
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Adjuvant Chemotherapy After Bladder Cancer Surgery Improved Survival Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests